Can POC Platforms Transform the CGT Market? with Vered Caplan, CEO of Orgenesis Inc.
In this episode, I talk to Vered Caplan, Chief Executive Officer at Orgenesis Inc. Their Point Of Care (POC) Platform aims to shape a Cell and Gene Therapies (CGT) ecosystem which can lower costs for innovators, accelerate treatments to market, and expand access for patients.Together, we discuss the importance of POC platforms post-COVID-19, and the important role of these technologies to help drive forward innovation in the CGT markets. We also talk about the future of the space and exciting plans in the pipeline for Orgenesis Inc.If you'd like to get in touch about this episode, would like to be a future podcast guest or want to learn more about CM Life Science's services; then please email me at [email protected]. Hosted on Acast. See acast.com/privacy for more information.